1. Behera D

9788180614347

10.5005/jp/books/10107_19

2/e

2005

13

1. LRS Institute of Tuberculosis and Respiratory Diseases, Sri Aurobindo Marg, Mehrauli, New Delhi, India, LRS Institute of Tuberculosis and Respiratory Diseases, Sri Aurobindo Marg, New Delhi, LRS Institute of Tuberculosis and Respiratory Diseases, New Delhi, India; Postgraduate Institute of Medical Education and Research, Chandigarh, India, Postgraduate Institute of Medical Education and Research, Chandigarh, LRS Institute of TB and Respiratory Diseases, New Delhi, India, Postgraduate Institute of Medical Education and Research, Chandigarh (India), Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; LRS Institute of Tuberculosis and Respiratory Diseases Sri Aurobindo Marg New Delhi, India, Lala Ram Swaroop Institute of Tuberculosis and Respiratory Diseases, Sri Aurobindo Marg, New Delhi, India, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Postgraduate Institute of Medical Education and Research Chandigarh, India, Postgraduate Institute of Medica

Alternate treatments in asthma, Alternate agents for bronchial asthma, Anti-IgE and soluble interleukin (IL)-4 receptor therapy, Azathioprine, Cyclosporine, Dapsone, Gold, High-dose inhaled corticosteroids, Hydroxychloroquine, Inhaled furosemide, Inhaled heparin, Leukotriene antagonists, Methotrexate, Oral and inhaled corticosteroids, Troleandomycin